These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26608521)

  • 1. Pseudoprogression in glioblastoma patients: the impact of extent of resection.
    Park HH; Roh TH; Kang SG; Kim EH; Hong CK; Kim SH; Ahn SS; Lee SK; Choi HJ; Cho J; Kim SH; Lee KS; Suh CO; Chang JH
    J Neurooncol; 2016 Feb; 126(3):559-66. PubMed ID: 26608521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.
    Brandes AA; Franceschi E; Tosoni A; Blatt V; Pession A; Tallini G; Bertorelle R; Bartolini S; Calbucci F; Andreoli A; Frezza G; Leonardi M; Spagnolli F; Ermani M
    J Clin Oncol; 2008 May; 26(13):2192-7. PubMed ID: 18445844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy.
    Li H; Li J; Cheng G; Zhang J; Li X
    Clin Neurol Neurosurg; 2016 Dec; 151():31-36. PubMed ID: 27764705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
    Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
    Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
    Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
    Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Surgical Resection, Disability, and Survival in Patients with Glioblastoma.
    Ahmadipour Y; Kaur M; Pierscianek D; Gembruch O; Oppong MD; Mueller O; Jabbarli R; Glas M; Sure U; El Hindy N
    J Neurol Surg A Cent Eur Neurosurg; 2019 Jul; 80(4):262-268. PubMed ID: 30965373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal extent of resection for glioblastoma according to site, extension, and size: a population-based study in the temozolomide era.
    Kim YJ; Lee DJ; Park CK; Kim IA
    Neurosurg Rev; 2019 Dec; 42(4):937-950. PubMed ID: 30612289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
    Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
    J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after glioblastoma resection: hope despite poor prognosis factors.
    Costa E; Lawson TM; Lelotte J; Fomekong E; Vaz RG; Renard L; Whenham N; Raftopoulos C
    J Neurosurg Sci; 2019 Jun; 63(3):251-257. PubMed ID: 29363298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When gross total resection of a glioblastoma is possible, how much resection should be achieved?
    Chaichana KL; Cabrera-Aldana EE; Jusue-Torres I; Wijesekera O; Olivi A; Rahman M; Quinones-Hinojosa A
    World Neurosurg; 2014; 82(1-2):e257-65. PubMed ID: 24508595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.
    Orringer D; Lau D; Khatri S; Zamora-Berridi GJ; Zhang K; Wu C; Chaudhary N; Sagher O
    J Neurosurg; 2012 Nov; 117(5):851-9. PubMed ID: 22978537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival.
    Abhinav K; Aquilina K; Gbejuade H; La M; Hopkins K; Iyer V
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1375-8. PubMed ID: 23333005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
    Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
    J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of extent of resection and recurrent surgery on clinical outcome and overall survival in a consecutive series of 170 patients for glioblastoma in intraoperative high field magnetic resonance imaging.
    Coburger J; Wirtz CR; König RW
    J Neurosurg Sci; 2017 Jun; 61(3):233-244. PubMed ID: 26149222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis.
    Adams H; Adams HH; Jackson C; Rincon-Torroella J; Jallo GI; Quiñones-Hinojosa A
    Childs Nerv Syst; 2016 Mar; 32(3):493-503. PubMed ID: 26767842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of resection affects prognosis for patients with glioblastoma in non-eloquent regions.
    Kow CY; Kim BJH; Park TI; Chen JCC; Vong CK; Kim JY; Shim V; Dragunow M; Heppner P
    J Clin Neurosci; 2020 Oct; 80():242-249. PubMed ID: 33099354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.